BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37311359)

  • 1. Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes.
    Wu L; Zhao YY; Li MR; Chang DY; Zhao MH; Chen M
    J Diabetes Complications; 2023 Aug; 37(8):108520. PubMed ID: 37311359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
    Basu M; Pulai S; Neogi S; Banerjee M; Bhattacharyya NP; Sengupta S; Mukhopadhyay P; Ray Chaudhury A; Ghosh S
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36517108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
    Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L
    Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Wang YH; Chang DY; Zhao MH; Chen M
    Oxid Med Cell Longev; 2022; 2022():2948248. PubMed ID: 36275902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort.
    Hirano T; Satoh N; Kodera R; Hirashima T; Suzuki N; Aoki E; Oshima T; Hosoya M; Fujita M; Hayashi T; Ito Y
    J Diabetes Investig; 2022 Apr; 13(4):657-667. PubMed ID: 34665936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
    Pichaiwong W; Homsuwan W; Leelahavanichkul A
    Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.